Article History
First Online: 6 August 2020
Declarations
:
: This study was funded by the University Hospital of North Norway and the University Hospital in Uppsala, Sweden. The statistical analyses were performed by a professional statistician at the Uppsala Clinical Research Centre, Uppsala, Sweden.
: Carl Swartling is a shareholder in Hidros International and is the owner of sweat clinics in Stockholm and Oslo. Øystein Grimstad and Bjørn Øivind Kvammen report no conflicts of interest.
: This study was conducted in accordance with the ethical standards of the responsible committees and the Declaration of Helsinki, and with the International Conference on Harmonization Guidelines for Good Clinical Practice. The trial was overseen by an independent Data and Safety Monitoring Board.
: The Regional Committee for Medical and Health Research Ethics in North Norway granted ethical approval (2017/149/REK Nord).
: Written informed consent was obtained from all patients or their proxies.
: Not applicable.
: The datasets generated and/or analysed during the current study are available from the corresponding author upon reasonable request.
: Not applicable.